• Join
  • Login
  • Contact

Search abstracts

Development of a model-based dose-individualisation approach with an application to routine clinical data

  • In: One size doesn't fit all: Dose individualisation with population pharmacology on Tuesday, 12 September 2017, 09:00-12:00
  • At: Seoul (South Korea) (2017)
  • Type: Presentation
  • By: GUK, Jinju (Yonsei University College of Medicine, Seoul, Korea, Republic Of)
  • Co-author(s): Jinju Guk
    Dongwoo Chae
    Kyungsoo Park
  • Abstract:

    With the development of new effective antiepileptic agents, the use of phenytoin has kept decreasing. Large inter-individual variability and narrow therapeutic range in drug concentration is another reason for decrease in phenytoin use. However, phenytoin is still an essential agent for second-line treatment of status epilepticus when patients do


  • The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress. Please login
Last update 4 October 2019

FIP Congresses